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Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the 
determination of the 3rd Generation PTH. 
 
Introduction: The Liaison 1-84 PTH allows the determination of (1-84) PTH without cross-
reaction to the (7-84) fragment. It is one of the first automated “3rd generation” PTH 
immunoassay. Unlike the “2nd generation” or “intact” PTH assays, the N-terminal antibody is 
specific for the first aminoacids of the peptide. The aim of that work was to evaluate the 
analytical performance of this new test. We also established the reference range of the 
parameter in a biologically well-defined healthy population.  
Material and methods: On two different Liaison automates, we evaluated the precision with 
a modified protocol based on CLSI EP-5A2: twelve serum pools were assayed in triplicate 
once per day on five different days. We established the analytical and the functional 
sensitivity with a method adapted from CLSI EP-17. Linearity was evaluated based on CLSI 
EP-6A. Recovery was determined according to CLSI EP-6P. Finally, we evaluated the 
measurement uncertainty, accuracy and b-expectation limits. We settled the b-expectation 
tolerance limits with b=0.95 and considered the method as valid if each future measurements 
of the same level had a probability of 95% to fall in the ±20% accepted limits of accuracy. We 
selected 60 male and 118 female for our reference population using these variables: age >18 
yo, levels of 25-OH vitamin D (25VTD) >32 ng/mL, calcium and phosphorous in the 
laboratory reference range and eGFR> 60 mL/min/1.73m² (estimated by the MDRD 
equation). All the subjects were Caucasian. We used the Kolmogornov-Smirnov test to check 
if the population was Gaussian.  
Results: Analytical and functional sensitivity were respectively ≤0.7 and ≤2.2 pg/mL. 
Repeatability and intermediate precision did not exceed 8% in the validated range. The mean 
recovery was 94.0±3.4%. The method was found to be linear until the 1/10 dilution. 
Measurement uncertainty was comprised between 14 and 7.4%. The accuracy profile built 
with the predictive tolerance interval method shows that, on average, 95% of the future results 
that will be generated by this method will be included in the computed tolerance intervals of 
±20% in the 4.3-1392 pg/mL studied range. Our selected population presented a mean 25VTD 
level of 41 ng/mL (Lowest:32; Highest: 93), a mean calcium of 2.32 mmol/L (Lowest:2.15 – 
Highest: 2.52) and a mean age of 56 yo (Lowest:19; Highest: 89). There was no significant 
difference between men and women. The reference range observed in this population was 4.6 
(90% CI: 3.4-5.9) – 26.8 (90% CI: 25.6-28.0) pg/mL.   
Conclusions: The Liaison 1-84 PTH is one of the first commercially available automated 3rd 
generation PTH assays. The analytical performances are remarkable, with an accuracy profile 
showing that the method is completely validated between 4.3 and 1392 pg/mL. We also 
established a reference range (4.6-26.8 pg/mL) on a very well biologically defined population. 
  
 
 
 
